Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
16.93
+0.03 (+0.18%)
Official Closing Price
Updated: 7:00 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Teva Pharmaceutical Industries ADR
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
15
16
Next >
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
July 27, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital...
Via
Benzinga
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits
July 27, 2022
Teva Pharmaceuticals (TEVA) stock is soaring higher on Wednesday after the pharmaceutical company reached a settlement in recent lawsuits.
Via
InvestorPlace
Teva Pharmaceutical Soars On $75 Million Opioid Deal In West Virginia
July 27, 2022
Teva will also provide the state with free opioid overdose treatment for a decade.
Via
Investor's Business Daily
What Is Going on With Teva Pharmaceuticals (TEVA) Stock Today?
July 12, 2022
TEVA stock, already trading far below its prior peak, may come under pressure in the near future due to the threat of ongoing litigation.
Via
InvestorPlace
Analyst Ratings for Teva Pharmaceutical Indus
June 14, 2022
Within the last quarter, Teva Pharmaceutical Indus (NYSE:TEVA) has observed the following analyst ratings:
Via
Benzinga
Why Teva Pharmaceutical Industries Stock Is Soaring
July 27, 2022
Teva Pharmaceutical Industries (NYSE: TEVA) shares are trading higher Wednesday after the company reported better-than-expected financial results.
Via
Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
July 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Teva Announces $4.25b Opioid Agreement With States, Native American Tribes
July 27, 2022
Teva has reached an agreement in principle with the working group of States' Attorneys General, counsel for Native American Tribes, and plaintiffs' lawyers representing the States and subdivisions, on...
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 27, 2022
Via
Benzinga
Why Generic Drugs Giant Teva Pharmaceutical Just Cut Its 2022 Outlook
May 03, 2022
Foreign exchange rates are weighing heavily on sales, according to the firm's CEO.
Via
Investor's Business Daily
Benzinga Before The Bell: Twitter Shareholder Proposal Date Set, T-Mobile's Strong FY22 Outlook, Shopify's Job Cuts And Other Top Financial Stories Wednesday, July 27
July 27, 2022
Reuters Monkeypox Emergency Could Last Months, According To Experts
Via
Benzinga
Alphabet, Microsoft And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
July 27, 2022
Pzena Investment Management, Inc (NYSE: PZN) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a rise...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 27, 2022
Good morning, investor! Wednesday starts with a breakdown of the biggest pre-market stock movers for traders to keep an eye on!
Via
InvestorPlace
Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session
July 27, 2022
Gainers Dave Inc. (NASDAQ: DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 26, 2022
Gainers
Via
Benzinga
Why Teva Pharmaceuticals Stock Is Soaring After Hours
July 26, 2022
Teva Pharmaceutical Industries (NYSE: TEVA) shares are surging in Tuesday's after-hours session after the company reported better-than-expected financial results.
Via
Benzinga
7 Growth Stocks to Buy on the Dip
July 22, 2022
These are the best growth stocks to buy on the dip. A, CDNS, GXTG, IVSG, IQV, PAYX, and SNPS are poised to deliver impressive returns.
Via
InvestorPlace
Will Bed Bath & Beyond (BBBY) Stock Really Fall to $1?
July 12, 2022
Bed Bath & Beyond (BBBY) stock is in the news today after an incredibly bearish analyst said the retailer's shares will fall to $1 a piece.
Via
InvestorPlace
New York Attorney General Says Teva Tried To Evade Accountability On Opioid Crisis: Report
July 12, 2022
Reuters reported that New York's attorney general said Teva Pharmaceutical Industries Ltd (NY
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
June 14, 2022
Upgrades
Via
Benzinga
Golden Cross Appears Before Teva Pharmaceutical Indus Investors
May 27, 2022
If history is any guide, there may be good fortune ahead for shares of Teva Pharmaceutical Indus (NYSE:TEVA). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be...
Via
Benzinga
Teva, Allergan Settle Opioid Lawsuit With West Virginia
May 25, 2022
U.S. affiliate of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached an agreement with the Attorney General of West Virginia that settles the state's opioid-related claims.
Via
Benzinga
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
May 17, 2022
Via
Benzinga
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
May 17, 2022
Prospects of a global opioid deal getting done in 2022 suggest a “potential path to upside” for Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) stock, according to BofA Securities.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2022
May 17, 2022
Via
Benzinga
4 Analysts Have This to Say About Teva Pharmaceutical Indus
May 12, 2022
Over the past 3 months, 4 analysts have published their opinion on Teva Pharmaceutical Indus (NYSE:TEVA) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
May 11, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022
May 04, 2022
Upgrades
Via
Benzinga
Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise
May 03, 2022
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.